结质瘤的先天性免疫信号:调节机制和向瘤进展中的潜在向
Edmund Jung1, Sara Al Jadidi1, Christina Piperi1
1Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Life (Basel, Switzerland)
|October 29, 2025
概括
天生的免疫受体在质瘤的发展和进展中起着关键作用. 针对这些受体提供了一个有希望的策略,以增强当前的质瘤治疗和加强免疫反应.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 质瘤是中枢神经系统的侵略性瘤,具有具有挑战性的治疗结果.
- 目前的治疗方法与复杂的瘤微环境和质瘤异质性作斗争.
- 天生的免疫受体越来越多地被认为是它们在质瘤发病过程中的作用.
研究的目的:
- 审查质瘤中先天性免疫受体的信号通路.
- 探索这些受体在质瘤病理和免疫逃避中的功能性作用.
- 讨论在质瘤治疗中准先天性免疫受体的治疗潜力.
主要方法:
- 关于质瘤先天性免疫受体研究的文献综述.
- 通过先天免疫受体激活的信号通路的分析.
- 探索先天免疫受体与瘤微环境之间的相互作用.
主要成果:
- 天生的免疫受体 (Toll-like,NOD-like,RIG-like,cGAS-STING, scavenger,C型学菌素) 显著影响质瘤的发展.
- 这些受体调节免疫反应,并通过与骨髓细胞和细胞因子的相互作用促进瘤生长.
- 准先天性免疫受体可能会在质瘤微环境中克服免疫逃避.
结论:
- 天生的免疫受体是质瘤进展和免疫逃避中的关键参与者.
- 针对这些受体,特别是与传统疗法相结合,显示出改善质瘤治疗疗效的希望.
- 对先天免疫受体信号的进一步研究对于开发针对质瘤的新型免疫调节策略至关重要.
关键词:
C型莱克受体是什么类型的类似于NOD的NOD.这是一个类似RIG的RIG.在TME中,它是最重要的.大脑瘤 大脑瘤cGAS-STING受体的使用.天生的免疫受体天生的免疫受体.拾尸体受体的拾尸体受体是什么这是一种类似于收费的收费系统.更多相关视频
09:17Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
2.7K
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
8.2K
相关概念视频
01:19Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K